Additional Information

Description

Cimzia 200mg 2mL Vial 2/Bx is a biologic medication used for the treatment of moderate-to-severe autoimmune conditions such as rheumatoid arthritis, Crohn’s disease, and ankylosing spondylitis. It contains the active ingredient certolizumab pegol, a tumor necrosis factor (TNF) inhibitor. This medication works by binding to and neutralizing TNF, a protein involved in inflammatory processes, reducing the activity of the immune system that causes inflammation.

The product is supplied in two Type I glass vials containing 200 mg of lyophilized CIMZIA. These vials are intended for reconstitution before injection. Each box includes two vials, two vials of sterile water for injection (2mL), syringes, needles, and alcohol swabs, providing all the necessary components for administration. The kit facilitates self-administration under proper medical guidance.

Cimzia is indicated for chronic inflammatory conditions and helps in managing symptoms and slowing disease progression. By reducing inflammation, it can improve quality of life for patients suffering from conditions like rheumatoid arthritis and Crohn’s disease. The medication is administered subcutaneously.